Joel Lundy

1.9k total citations
47 papers, 1.5k citations indexed

About

Joel Lundy is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Joel Lundy has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Joel Lundy's work include Cancer, Stress, Anesthesia, and Immune Response (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Virus-based gene therapy research (6 papers). Joel Lundy is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Virus-based gene therapy research (6 papers). Joel Lundy collaborates with scholars based in United States. Joel Lundy's co-authors include Edmund J. Lovett, Ann D. Thor, Jeffrey Schlom, Frank B. Fromowitz, Michael V. Viola, Gerald C. Finkel, James H. Foster, Yousri Mishriki, Philip B. Conran and Roger Grimson and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Joel Lundy

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Lundy United States 20 597 465 273 263 251 47 1.5k
James A. Belli United States 23 336 0.6× 448 1.0× 522 1.9× 174 0.7× 340 1.4× 50 1.8k
Robert J. Spiegel United States 23 611 1.0× 800 1.7× 130 0.5× 309 1.2× 268 1.1× 73 2.2k
Thomas S. Winokur United States 23 354 0.6× 603 1.3× 252 0.9× 121 0.5× 315 1.3× 57 1.7k
Nick J. Gonchoroff United States 28 562 0.9× 791 1.7× 134 0.5× 469 1.8× 298 1.2× 41 2.4k
Lucien Israël France 23 697 1.2× 341 0.7× 74 0.3× 283 1.1× 260 1.0× 107 1.5k
J Koudstaal Netherlands 25 371 0.6× 513 1.1× 104 0.4× 224 0.9× 245 1.0× 61 2.1k
Robert N. Taub United States 27 722 1.2× 718 1.5× 240 0.9× 513 2.0× 684 2.7× 79 2.3k
William I. Smith United States 19 217 0.4× 324 0.7× 181 0.7× 148 0.6× 334 1.3× 38 1.3k
G Wong Canada 18 820 1.4× 433 0.9× 109 0.4× 578 2.2× 162 0.6× 22 2.0k
Wilson Cb United States 26 291 0.5× 482 1.0× 184 0.7× 136 0.5× 459 1.8× 90 2.2k

Countries citing papers authored by Joel Lundy

Since Specialization
Citations

This map shows the geographic impact of Joel Lundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Lundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Lundy more than expected).

Fields of papers citing papers by Joel Lundy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Lundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Lundy. The network helps show where Joel Lundy may publish in the future.

Co-authorship network of co-authors of Joel Lundy

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Lundy. A scholar is included among the top collaborators of Joel Lundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Lundy. Joel Lundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lundy, Joel, et al.. (1991). Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.. PubMed. 138(6). 1527–34. 51 indexed citations
2.
Lundy, Joel. (1990). The Use of Fine-Needle Aspirates of Breast Cancers to Evaluate Hormone-Receptor Status. Archives of Surgery. 125(2). 174–174. 10 indexed citations
3.
Kline, Tilde S., et al.. (1989). Monoclonal antibody b72.3. an adjunct for evaluation of suspicious aspiration biopsy cytology from the breast. Cancer. 63(11). 2253–2256. 10 indexed citations
4.
Schuss, Allan, et al.. (1988). Reactivity of the Monoclonal Antibody B72.3 with Fetal Antigen: Correlation with Expression of TAG-72 in Human Carcinomas. Cancer Investigation. 6(3). 279–287. 12 indexed citations
5.
Lundy, Joel, et al.. (1988). Phenotypic markers for a spectrum of colonic polyps and cancers. Diseases of the Colon & Rectum. 31(11). 857–863. 2 indexed citations
6.
Lundy, Joel, et al.. (1988). Immunocytochemistry with monoclonal antibody B72.3 applied to a spectrum of benign and malignant breast aspirates — strengths and pitfalls. Breast Cancer Research and Treatment. 12(3). 259–266. 3 indexed citations
7.
Lundy, Joel, et al.. (1988). Immunoperoxidase studies by monoclonal antibody B72.3 applied to breast aspirates: Diagnostic considerations. Diagnostic Cytopathology. 4(2). 95–98. 9 indexed citations
8.
Fromowitz, Frank B., Michael V. Viola, Yousri Mishriki, et al.. (1987). ras p21 Expression in the progression of breast cancer. Human Pathology. 18(12). 1268–1275. 146 indexed citations
9.
Welch, John P., et al.. (1987). Management of endoscopically removed malignant colon polyps. Journal of Surgical Oncology. 36(2). 116–121. 27 indexed citations
10.
Grimson, Roger, et al.. (1987). Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis.. PubMed. 31(5). 557–62. 8 indexed citations
11.
Patronas, N J, Jack S. Cohen, Richard H. Knop, et al.. (1986). Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.. PubMed. 70(3). 391–5. 29 indexed citations
12.
Lundy, Joel, F. Mornex, Andrew M. Keenan, John W. Greiner, & David Colcher. (1986). Radioimmunodetection of human colon carcinoma xenografts in visceral organs of congenitally athymic mice. Cancer. 57(3). 503–509. 8 indexed citations
13.
Lundy, Joel, Ann D. Thor, Ronald M. Maenza, et al.. (1985). Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Research and Treatment. 5(3). 269–276. 56 indexed citations
14.
Lundy, Joel, et al.. (1983). Surgery, Trauma and Immune Suppression Evolving the Mechanism. Annals of Surgery. 197(4). 434–438. 64 indexed citations
15.
Simon, Richard H., et al.. (1980). Electrical Stimulation of the Midbrain Mediates Metastatic Tumor Growth. Science. 209(4461). 1132–1133. 24 indexed citations
16.
Lundy, Joel, Edmund J. Lovett, Steven M. Wolinsky, & Philip B. Conran. (1979). Immune impairment and metastatic tumor growth.The need for an immunorestorative drug as an adjunct to surgery. Cancer. 43(3). 945–951. 58 indexed citations
17.
Lundy, Joel, et al.. (1978). Pulmonary granulomas in a patient on MER therapy.. PubMed. 50(6). 665–8. 3 indexed citations
18.
Lundy, Joel, et al.. (1977). Chemoimmunotherapy of a murine fibrosarcoma: Critical factors for success of combined modality therapy. Journal of Surgical Oncology. 9(4). 339–345. 3 indexed citations
19.
Lovett, Edmund J. & Joel Lundy. (1977). THE EFFECT OF THIABENDAZOLE IN A MIXED LEUKOCYTE CULTURE. Transplantation. 24(2). 93–98. 16 indexed citations
20.
Lundy, Joel, et al.. (1976). Thiabendazole: a potential adjuvant in cancer therapy.. PubMed. 80(5). 636–40. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Belli Breakdown of academic impact, for papers by Robert J. Spiegel Breakdown of academic impact, for papers by Thomas S. Winokur Breakdown of academic impact, for papers by Nick J. Gonchoroff Breakdown of academic impact, for papers by Lucien Israël Breakdown of academic impact, for papers by J Koudstaal Breakdown of academic impact, for papers by Robert N. Taub Breakdown of academic impact, for papers by William I. Smith Breakdown of academic impact, for papers by G Wong Breakdown of academic impact, for papers by Wilson Cb
Rankless by CCL
2026